close
close

PatientSeek identifies a genetic signature that distinguishes a4b7 integrin therapy-responsive and non-responsive populations in inflammatory bowel disease

PatientSeek identifies a genetic signature that distinguishes a4b7 integrin therapy-responsive and non-responsive populations in inflammatory bowel disease

C4X Discovery Holdings Limited

PatientSeek identifies a genetic signature that A4B7 Populations That Respond and Non-Respond to Integrin Therapy in Inflammatory Bowel Disease

Progress with accurate patient selection method – the right patient for the right drug